APA (7th ed.) Citation

Dardiotis, E., Perpati, G., Borsos, M., Nikolaidis, I., Tzanetakos, D., Deretzi, G., . . . Kostadima, V. (2022). Real-World Assessment of Quality of Life in Patients with Relapsing Remitting Multiple Sclerosis Treated with Teriflunomide for Two Years: Patient-Reported Outcomes from the AURELIO Study in Greece. Neurology & Therapy, 11(3), 1375. https://doi.org/10.1007/s40120-022-00384-2

Chicago Style (17th ed.) Citation

Dardiotis, Efthymios, et al. "Real-World Assessment of Quality of Life in Patients with Relapsing Remitting Multiple Sclerosis Treated with Teriflunomide for Two Years: Patient-Reported Outcomes from the AURELIO Study in Greece." Neurology & Therapy 11, no. 3 (2022): 1375. https://doi.org/10.1007/s40120-022-00384-2.

MLA (9th ed.) Citation

Dardiotis, Efthymios, et al. "Real-World Assessment of Quality of Life in Patients with Relapsing Remitting Multiple Sclerosis Treated with Teriflunomide for Two Years: Patient-Reported Outcomes from the AURELIO Study in Greece." Neurology & Therapy, vol. 11, no. 3, 2022, p. 1375, https://doi.org/10.1007/s40120-022-00384-2.